Biogen to Present at the Morgan Stanley 17th Annual Global Healthcare Conference.
ENPNewswire-August 28, 2019--Biogen to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
(C)2019 ENPublishing - http://www.enpublishing.co.uk
Release date- 27082019 - Cambridge - Biogen Inc. (Nasdaq: BIIB) announced today that it will present at the Morgan Stanley 17th Annual Global Healthcare Conference.
The webcast will be live on Monday, September 9, at 9:55 a.m. ET. To access the live webcast, please visit Biogen's Investors section at www.biogen.com/investors. An archived version of the webcast will be available following the presentation.
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world's first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp, and today has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing neuroscience research programs in multiple sclerosis and neuroimmunology, neuromuscular disorders, movement disorders, Alzheimer's disease and dementia, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain.
[Editorial queries for this story should be sent to email@example.com]
((Distributed via M2 Communications - http://www.m2.com))
|Printer friendly Cite/link Email Feedback|
|Date:||Aug 28, 2019|
|Previous Article:||ABIONYX Pharma - Change of name and stock symbol/mnemonic of ABIONYX Pharma shares as of August 29, 2019.|
|Next Article:||Christopher & Banks Corporation Announces Second Quarter 2019 Earnings Conference Call.|